Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02383-0003-0000-1 |
Chemical Name: | Maleic hydrazide |
CASRN: | 123-33-1 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 702766_SCE |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Positive |
No Activation | 2 | Positive |
No Activation | 3 | Positive |
No Activation | 4 | Negative |
Induced Rat Liver S9 | 1_S9 | Negative |
Induced Rat Liver S9 | 2_S9 | Positive |
Induced Rat Liver S9 | 3_S9 | Negative |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1049 | 409 | 0.390 | 8.18 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 16 | 50 | 1034 | 505 | 0.488 | 10.10 | 26.0 | 25.263 |
50 | 50 | 1033 | 544 | 0.527 | 10.88 | 26.0 | 35.067 | ||
160 | 50 | 1027 | 848 | 0.826 | 16.96 | 26.0 | 111.776 | ||
500 | 50 | 1043 | 1799 | 1.725 | 35.98 | 26.0 | 342.384 | ||
Positive Control | Mitomycin-C | 0.01 | 50 | 1024 | 2081 | 2.032 | 41.62 | 26.0 | 421.224 |
Trend: | 34.538 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1047 | 386 | 0.369 | 7.72 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 16 | 50 | 1046 | 403 | 0.385 | 8.06 | 26.0 | 4.504 |
50 | 50 | 1047 | 495 | 0.473 | 9.90 | 26.0 | 28.238 | ||
160 | 50 | 1042 | 705 | 0.677 | 14.10 | 26.0 | 83.519 | ||
500 | 50 | 1041 | 1740 | 1.671 | 34.80 | 26.0 | 353.375 | ||
1600 | 0 | 0 | 0 | 0.000 | 0.00 | 26.0 | N/A | ||
5000 | 0 | 0 | 0 | 0.000 | 0.00 | 26.0 | N/A | ||
Positive Control | Mitomycin-C | 0.005 | 50 | 1041 | 1707 | 1.640 | 34.14 | 26.0 | 344.777 |
Trend: | 34.985 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1033 | 422 | 0.409 | 8.44 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 50 | 50 | 1049 | 504 | 0.480 | 10.08 | 26.0 | 17.610 |
160 | 50 | 1032 | 663 | 0.642 | 13.26 | 26.0 | 57.261 | ||
500 | 50 | 1046 | 1294 | 1.237 | 25.88 | 26.0 | 202.824 | ||
1000 | 50 | 1040 | 1710 | 1.644 | 34.20 | 26.0 | 302.486 | ||
2000 | 50 | 1031 | 2325 | 2.255 | 46.50 | 26.0 | 452.017 | ||
3000 | 50 | 1042 | 2866 | 2.750 | 57.32 | 26.0 | 573.281 | ||
4000 | 50 | 1031 | 3154 | 3.059 | 63.08 | 26.0 | 648.843 | ||
Positive Control | Mitomycin-C | 0.005 | 100 | 1030 | 1761 | 1.710 | 17.61 | 26.0 | 318.514 |
Trend: | 67.645 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1027 | 380 | 0.370 | 7.60 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 1000 | 50 | 1032 | 396 | 0.384 | 7.92 | 26.0 | 3.706 |
2000 | 50 | 1037 | 434 | 0.419 | 8.68 | 26.0 | 13.109 | ||
3000 | 50 | 1035 | 410 | 0.396 | 8.20 | 26.0 | 7.061 | ||
4000 | 50 | 1033 | 416 | 0.403 | 8.32 | 26.0 | 8.838 | ||
Positive Control | Mitomycin-C | 0.005 | 50 | 1030 | 1761 | 1.710 | 35.22 | 26.0 | 362.071 |
Trend: | 1.397 | ||||||||
Probability: | 0.081 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1033 | 391 | 0.379 | 7.82 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 500 | 50 | 1033 | 394 | 0.381 | 7.88 | 26.0 | 0.767 |
1000 | 50 | 1047 | 463 | 0.442 | 9.26 | 26.0 | 16.831 | ||
2000 | 50 | 1037 | 416 | 0.401 | 8.32 | 26.0 | 5.983 | ||
3000 | 50 | 1038 | 436 | 0.420 | 8.72 | 26.0 | 10.972 | ||
4000 | 50 | 1039 | 458 | 0.441 | 9.16 | 26.0 | 16.459 | ||
Positive Control | Cyclophosphamide | 1.5 | 50 | 1040 | 1584 | 1.523 | 31.68 | 26.0 | 302.388 |
Trend: | 2.283 | ||||||||
Probability: | 0.011 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1040 | 405 | 0.389 | 8.10 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 2000 | 50 | 1027 | 406 | 0.395 | 8.12 | 26.0 | 1.516 |
3000 | 50 | 1039 | 558 | 0.537 | 11.16 | 26.0 | 37.910 | ||
4000 | 50 | 1048 | 714 | 0.681 | 14.28 | 26.0 | 74.951 | ||
Positive Control | Cyclophosphamide | 2 | 50 | 1035 | 2262 | 2.186 | 45.24 | 26.0 | 461.217 |
Trend: | 10.304 | ||||||||
Probability: | 0.000 |
Dose µg/mL | Number Cells Examined | Number Chromosomes Examined | Total Number SCEs | SCE / Chromosome | SCE / Cell | Hours in BRDU | % Increase Over Solvent Control | ||
---|---|---|---|---|---|---|---|---|---|
Vehicle Control | Negative (Not Specified) | 0 | 50 | 1040 | 511 | 0.491 | 10.22 | 26.0 | 0.000 |
Test Chemical | Maleic hydrazide | 1000 | 50 | 1035 | 465 | 0.449 | 9.30 | 26.0 | -8.562 |
2000 | 50 | 1036 | 460 | 0.444 | 9.20 | 26.0 | -9.633 | ||
3000 | 50 | 1041 | 467 | 0.449 | 9.34 | 26.0 | -8.698 | ||
4000 | 50 | 1040 | 495 | 0.476 | 9.90 | 26.0 | -3.131 | ||
Positive Control | Cyclophosphamide | 2 | 50 | 1049 | 2344 | 2.235 | 46.88 | 26.0 | 354.773 |
Trend: | -0.650 | ||||||||
Probability: | 0.742 |